Periodic Reporting for period 1 - AR-DDR (Co-targeting androgen receptor signalling and DNA damage repair for precision therapy in advanced prostate cancer)

Prostate cancer is the 2nd most common cancer type in the western world, and the most prevalent in men. When the disease spreads to other organs, metastatic prostate cancer is an invariably lethal disease. Prostate cancer is addicted to androgen signalling; chemical...